-
Decomposing the "Weight Loss Drug" Capital Feast: Novo Nordisk and Lilly Struggle for Nearly 20 Years, True and False Concepts Fly Together
If you want to select the concept with the highest attention in the capital market in 2023, the "slimming elixir" is undoubtedly the best choice. Musk's shout, the years of entanglement between the t ...